Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis

Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis

Objectives Determine whether an ultrathin biodegradable polymer sirolimus-eluting stent (‘Orsiro’—BP-SES) has clinical benefits over second-generation durable polymer drug-eluting stents (DP-DES).Methods We conducted a prospective systematic review and meta-analysis of randomised clinical trials com...

Full description

Bibliographic Details
Main Authors:	Michael Parkinson, Mohammad Riashad Monjur, Christian F Said, Paul Bamford, Richard Szirt, Thomas Ford
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-12-01
Series:	Open Heart
Online Access:	https://openheart.bmj.com/content/7/2/e001394.full

Similar Items

Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials
by: Ping Zhu, et al.
Published: (2018-08-01)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
by: Rainer Zbinden, et al.
Published: (2016-03-01)

Efficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis.
by: Yicong Ye, et al.
Published: (2013-01-01)

Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting stent in patients with coronary artery disease
by: Suresh Patted, et al.
Published: (2020-07-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
by: Paweł Gąsior, et al.
Published: (2018-11-01)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
by: Da Hyon Lee, et al.
Published: (2017-01-01)

The outcome of ultrathin-strut biodegradable polymer-coated sirolimus-eluting stents in coronary artery disease patients – A feasibility study
by: Prashanth Panduranga, et al.
Published: (2023-01-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
by: Juan F. Iglesias, et al.
Published: (2019-11-01)

High rate of uncovered struts in latest generation drug-eluting stents with durable, biodegradable polymer or lack of it 1 month after implantation
by: Alicia Calvo-Fernández, et al.
Published: (2023-02-01)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
by: Flavius-Alexandru Gherasie, et al.
Published: (2023-04-01)

Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review
by: Attilio Leone, et al.
Published: (2022-08-01)

Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
by: Ajmera P, et al.
Published: (2019-10-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
by: Juntao Yin, et al.
Published: (2023-01-01)

Flexibility of Biodegradable Polymer Stents with Different Strut Geometries
by: Chong Chen, et al.
Published: (2020-07-01)

Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: a meta-analysis
by: Tingting Wei, et al.
Published: (2022-06-01)

One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis
by: Hong Wang, et al.
Published: (2022-10-01)

Nine-month Angiographic and Two-year Clinical Follow-up of Novel Biodegradable-polymer Arsenic Trioxide-eluting Stent Versus Durable-polymer Sirolimus-eluting Stent For Coronary Artery Disease
by: Li Shen, et al.
Published: (2015-01-01)

Clinical Outcomes of Biodegradable versus Durable Polymer Drug Eluting Stents in Rotational Atherectomy: Results from ROCK Registry
by: Kyung An Kim, et al.
Published: (2022-10-01)

Safety and Efficacy of Post-Dilation in Percutaneous Coronary Intervention Using Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents
by: Yonghoon Shin, et al.
Published: (2023-09-01)

Efficacy and safety of durable versus biodegradable polymer drug-eluting stents in patients with acute myocardial infarction complicated by cardiogenic shock
by: Woo Jin Jang, et al.
Published: (2024-03-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
by: Walid Maamoun
Published: (2013-09-01)

Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry
by: Pannipa Suwannasom, et al.
Published: (2021-10-01)

Five-year outcomes of biodegradable versus second-generation durable polymer drug-eluting stents used in complex percutaneous coronary intervention
by: Na Xu, et al.
Published: (2023-02-01)

Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery.
by: Takeshi Ijichi, et al.
Published: (2019-01-01)

Optimized sirolimus-eluting stent by coating asymmetrically with biodegradable and cytocompatible polymers
by: Seong Min Kim, et al.
Published: (2016-02-01)

Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years)
by: Adrian Włodarczak, et al.
Published: (2024-03-01)

Faster smooth muscle cell coverage in ultrathin-strut drug-eluting stent leads to earlier re-endothelialization
by: Dongwoo Hahn, et al.
Published: (2023-05-01)

Long-Term Clinical Outcomes Between Biodegradable and Durable Polymer Drug-Eluting Stents: A Nationwide Cohort Study
by: Seung-Jun Lee, et al.
Published: (2022-04-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
by: Xiao-Fang Tang, et al.
Published: (2018-08-01)

Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies)
by: Lansky, Alexandra J., et al.
Published: (2018)

Performance evaluation of biodegradable polymer sirolimus and ascorbic acid eluting stent systems
by: Won-Il Jo, et al.
Published: (2022-10-01)

Ultrathin, biodegradable polymer-coated everolimus-eluting stents for patients undergoing percutaneous coronary intervention: Final three-year results of the PERFORM-EVER registry
by: Sridhar Kasturi, et al.
Published: (2023-11-01)

Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus
by: Tobias Lenz, et al.
Published: (2021-06-01)

Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus
by: Alexander Thomas, MD, et al.
Published: (2022-03-01)

Real-World Long-Term Clinical Outcomes of Ultrathin Strut Biodegradable Polymer Drug-Eluting Stents in Korean ST-Segment-Elevation Myocardial Infarction (STEMI) Patients with or without Acute Heart Failure Undergoing Primary Percutaneous Coronary Intervention
by: Albert Youngwoo Jang, et al.
Published: (2021-12-01)

Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
by: Kyeong Ho Yun, et al.
Published: (2021-01-01)

Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis
by: Hong Wang, et al.
Published: (2023-08-01)

Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study
by: Magdalena Dobrolińska, et al.
Published: (2020-06-01)